How many employees does Inhibrx Biosciences Inc. have?

Inhibrx Biosciences Inc. reported 109 employees for the fiscal year ending Dec 2025, in the annual report it filed on March 19, 2026. That is down 30.1% from a year earlier.

What is Inhibrx Biosciences Inc.'s revenue per employee?

Inhibrx Biosciences Inc. brought in $1.3M of revenue in fiscal Dec 2025, which is $12K per employee. That ranks 103 of 108 companies we track in Biotechnology, where the median is $459K.

Where do these numbers come from?

Employee counts and revenue are taken from each company's own annual report (Form 10-K). Open roles are counted from the company's public job board where we have matched one. Companies report headcount once a year, sometimes rounded, so small changes can be noise.

Company data

Inhibrx Biosciences Inc. employees and revenue per employee

INBX · Biotechnology · $1.39B market cap

Inhibrx Biosciences Inc. had 109 employees at the end of fiscal Dec 2025, down 30.1% from a year earlier. Revenue for the year was $1.3M, up 550.0% from a year earlier, or $12K per employee. Revenue held up or grew while headcount stayed flat or fell.

Employees

109

-30.1% YoY

Revenue

$1.3M

+550.0% YoY

Revenue / employee

$12K

Peer median $459K

Rank in industry

103 of 108

Biotechnology

Headcount against revenue

Both lines start at 100 in the first year we hold, so you can see which one grew faster.

EmployeesRevenueIndexed to 100 in Dec 2024

Hover a year for the numbers.

INBX employees and revenue by fiscal year
Year ending	Employees	Revenue	Per employee	Staff YoY	Revenue YoY
Dec 2025	109	$1.3M	$12K	-30.1%	+550.0%
Dec 2024	156	$200,000	$1K	—	—

Open roles: we have not matched a verified job board for this company yet.

Employees, last six fiscal years

Revenue per employee, last six fiscal years

Inhibrx Biosciences Inc. against similar companies

The closest industry peers by revenue, from Biotechnology.

Company	Employees	Revenue	Revenue / employee	Shape
CGON CG Oncology Inc.	142	$4.0M	$28K	Efficient growth
STTK Shattuck Labs, Inc.	40	$1.0M	$25K	Contracting
DNTH Dianthus Therapeutics, Inc.	92	$2.0M	$22K	Hiring into decline
ABSI Absci Corporation	140	$2.8M	$20K	Contracting
INBX Inhibrx Biosciences Inc.	109	$1.3M	$12K	Leaner
NGNE Neurogene Inc.	107	$925,000	$9K	—
CLDX Celldex Therapeutics, Inc.	198	$1.5M	$8K	Hiring into decline
ARTV Artiva Biotherapeutics, Inc.	89	$251,000	$3K	—
AKTS Aktis Oncology, Inc.	200,000	$6.5M	$32	—

Every Healthcare company

Questions about Inhibrx Biosciences Inc.

How many employees does Inhibrx Biosciences Inc. have?: Inhibrx Biosciences Inc. reported 109 employees for the fiscal year ending Dec 2025, in the annual report it filed on March 19, 2026. That is down 30.1% from a year earlier.
What is Inhibrx Biosciences Inc.'s revenue per employee?: Inhibrx Biosciences Inc. brought in $1.3M of revenue in fiscal Dec 2025, which is $12K per employee. That ranks 103 of 108 companies we track in Biotechnology, where the median is $459K.
Where do these numbers come from?: Employee counts and revenue are taken from each company's own annual report (Form 10-K). Open roles are counted from the company's public job board where we have matched one. Companies report headcount once a year, sometimes rounded, so small changes can be noise.

Free game

Think you can pick better than the S&P 500?

Pick 15 stocks, lock them in, and we score them against the index every trading day for ten years. Free, with a public leaderboard.

Enter the challenge

More data

Compare INBX with the rest of the market

See who earns the most per employee, who is hiring, and who is cutting, across every company we track.

Leaderboard Healthcare

Source: employee counts and revenue as stated in Inhibrx Biosciences Inc.'s annual reports (Form 10-K), latest filed March 19, 2026. This is data, not a recommendation to buy or sell INBX.